Sevelamer Carbonate
Product Images NDC 67787-407

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Sevelamer Carbonate (NDC 67787-407). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Invagen Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Sevelamer Carbonate Tabs 800mg)

Sevelamer carbonate tablets packaging label from InvaGen Pharmaceuticals Inc. The label shows the proprietary name Sevelamer Carbonate Tablets with a strength of 800 mg per film coated tablet. The package contains 30 film coated tablets and is marked Rx only. The label includes dosage information, inactive ingredients, storage instructions, and a barcode.*

FDA Label Image

Chemical Structure/figure 1 (Sevelamer Carbonate Tabs Fig01)

Chemical structure of Sevelamer carbonate showing its polymeric form with repeating units containing amine and ammonium groups along with carbonate ions.*

FDA Label Image

Figure 2 (Sevelamer Carbonate Tabs Fig02)

A curve graph showing the percentage of patients achieving varying levels of serum phosphorus reduction. The x-axis represents the reduction in serum phosphorus (mg/dL), ranging from -4 to 8, and the y-axis shows the percentage of patients with at least that reduction, from 0% to 100%. Two lines compare Sevelamer Hydrochloride and an active control. Annotations indicate worsened increase (left), improved reduction (right), and reduction from baseline at center (0).*

FDA Label Image

Figure 3 (Sevelamer Carbonate Tabs Fig03)

A line graph depicting phosphorus change from baseline over a 52-week study period. The x-axis represents study weeks, ranging from 0 to 52, while the y-axis shows phosphorus change from baseline, ranging from -5 to 2. Two treatment groups are compared: Sevelamer Hydrochloride (black circles) and Active-Control (red squares). Both groups show an initial decrease in phosphorus levels that stabilizes over time.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.